VIA
NARI

Vident Investment Advisory’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Vident Investment Advisory’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,564
Closed -$220K – 1356
2023
Q1 		$220K Buy
+3,564
New +$214K 0.01% 1072

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vident Investment Advisory's NARI Position: Q2 2023 in Review

Vident Investment Advisory sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2023, closing a stake of 3,564 shares — an estimated $220K sold.

Vident Investment Advisory first reported a position in NARI in Q1 2023 and held it in 1 quarter. The position peaked at $220K in Q1 2023. 250 funds tracked by Wall St. Rank hold NARI as of Q2 2023.

  • Vident Investment Advisory reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 3,564 Inari Medical, Inc. Common Stock shares in Q2 2023, an estimated $220K.
  • Vident Investment Advisory first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Vident Investment Advisory's Inari Medical, Inc. Common Stock position peaked at $220K in Q1 2023.
  • 250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.